Moreover, the repair of 8-oxoG by OGG1-BER is an important event in cancer therapy strategies based on a ROS-mediated mechanism, so the use of a ROS-inducing agent, in combination with 8-oxoG repair enzyme inhibitors, may be an attractive new approach to improving therapeutic outcomes. This evidence concerns the gene OGG1 and cancer.